Active	Status	Sponsor type	Region	Phase	Filter
7 Active 5 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guenette, Jordan A
NCT03522831: CF Bronchodilation	Active, not recruiting	N/A	20	Canada	Salbutamol, Placebo	University of British Columbia	Lung Diseases, Cystic Fibrosis	12/24	12/24
HOPE-IPF, NCT02551068: High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib	Recruiting	N/A	88	Canada	60% Oxygen, Standard of Care	University of British Columbia, Boehringer Ingelheim	Idiopathic Pulmonary Fibrosis	12/26	12/26
NCT04299945: Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease	Recruiting	N/A	15	Canada	concentrated beetroot juice (400mg of nitrate per serving), concentrated beetroot juice (trace amounts of nitrate per serving)	University of British Columbia	Interstitial Lung Disease	12/26	12/26
NCT03800017: Skeletal Muscle Function in Interstitial Lung Disease	Recruiting	N/A	40	Canada	Hyperoxia	University of British Columbia	Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Scleroderma, Nonspecific Interstitial Pneumonia	12/26	12/26
NCT05279040: Trikafta Exercise Study in Cystic Fibrosis	Recruiting	N/A	20	Canada	Trikafta, Elexacaftor/Tezacaftor/Ivacaftor	University of British Columbia	Cystic Fibrosis, Lung Diseases	12/25	12/25
Dhillon, Satvir
NCT03800017: Skeletal Muscle Function in Interstitial Lung Disease	Recruiting	N/A	40	Canada	Hyperoxia	University of British Columbia	Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Scleroderma, Nonspecific Interstitial Pneumonia	12/26	12/26
NCT05279040: Trikafta Exercise Study in Cystic Fibrosis	Recruiting	N/A	20	Canada	Trikafta, Elexacaftor/Tezacaftor/Ivacaftor	University of British Columbia	Cystic Fibrosis, Lung Diseases	12/25	12/25